Superworth

DexCom PE ratio DXCM

Share price divided by earnings per share over the last twelve months, since 2018.

Today, Nov 3, 2026
33.6×
8-year median
102×
Against its 8-year history
8th
percentile: 0 is its lowest day, 100 its highest
8-year range
26.0× to 343×
Peer median
24.3×

DexCom's PE ratio is 33.6× as of Nov 3, 2026: a share price of $84.59 against $2.52 of earnings per share over the last twelve months.

That is below its 8-year median of 102×, lower than on 92% of days in the last 8 years.

Over that time it ranged from 26.0× in May 2026 to 343× in Apr 2022.

The median for 9 medical device stocks of a similar size is 24.3×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far33.6×26.0×40.8×
202537.7×30.7×66.9×
202448.3×39.8×140×
2023136×88.6×213×
2022209×77.6×343×
2021101×64.1×170×
2020153×131×308×
2019316×247×318×
2018252×230×318×

Against its peers

Companies in Medical - Devices nearest DexCom's size, closest first, today.

Where DexCom ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on DexCom

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.